Wolverine Trading, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $5.94 Million - $6.97 Million	5,800 Added 19.73%	35,200 $37 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $7.86 Million - $9.53 Million	-8,900 Reduced 23.24%	29,400 $30.9 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $10.1 Million - $11.1 Million	-11,200 Reduced 22.63%	38,300 $36.9 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $17.2 Million - $19.6 Million	22,200 Added 81.32%	49,500 $43.5 Million
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $1.25 Million - $1.52 Million	1,800 Added 7.06%	27,300 $22.5 Million
Q2 2023 Aug 23, 2023	BUY	$700.03 - $830.35 $17.9 Million - $21.2 Million	25,500 New	25,500 $18.3 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $50.8 Million - $55.2 Million	72,000 Added 421.05%	89,100 $64.3 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $4.88 Million - $6.16 Million	8,500 Added 98.84%	17,100 $11.8 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $1.21 Million - $1.63 Million	-2,200 Reduced 20.37%	8,600 $5.14 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $18 Million - $21.1 Million	-30,200 Reduced 73.66%	10,800 $7.48 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $4.24 Million - $5.23 Million	7,800 Added 23.49%	41,000 $26.3 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $3.96 Million - $4.7 Million	-6,900 Reduced 17.21%	33,200 $20.1 Million
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $4.49 Million - $5.31 Million	9,500 Added 31.05%	40,100 $21.9 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $12.4 Million - $15.2 Million	-27,800 Reduced 47.6%	30,600 $14.4 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $7.6 Million - $9.67 Million	15,900 Added 37.41%	58,400 $27.9 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $1.09 Million - $1.32 Million	-2,000 Reduced 4.49%	42,500 $24.4 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $22 Million - $28.7 Million	44,500 New	44,500 $27.2 Million
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $30.1 Million - $44.3 Million	-89,600 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $3.56 Million - $4.89 Million	13,000 Added 16.97%	89,600 $33.5 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $20.9 Million - $24.4 Million	76,600 New	76,600 $20.9 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $24.1 Million - $28.5 Million	-64,800 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.38 Million - $1.65 Million	4,100 Added 6.75%	64,800 $23.5 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $1.02 Million - $1.18 Million	-2,900 Reduced 4.56%	60,700 $24.5 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $5.65 Million - $7.05 Million	-17,900 Reduced 21.96%	63,600 $21.9 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $5.34 Million - $7 Million	-14,900 Reduced 15.46%	81,500 $30.6 Million
Q3 2017 Nov 15, 2017	BUY	$431.38 - $504.0 $41.6 Million - $48.6 Million	96,400	96,400 $43.1 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account